Growing number of Salmonella illnesses and outbreaks linked to moringa leaf products

Translate to Spanish or other 102 languages!

Information shows Mogo brand moringa capsules may be making people sick. These products have been recalled but may still be in homes. Image courtesy of CDC. Bgd for illustration purposes
Information shows Mogo brand moringa capsules may be making people sick. These products have been recalled but may still be in homes. Image courtesy of CDC. Bgd for illustration purposes
- Advertisement -

CDC – A new CDC food safety alert has been posted, and another from early 2026 has been re-opened with new cases, on two separate Salmonella outbreaks linked to moringa leaf products: 

Key Points:

  • Eighteen people across 14 states have gotten sick with the same strain of Salmonella. Seven people have been hospitalized, and no deaths have been reported.
  • Information shows Mogo brand moringa capsules may be making people sick. These products have been recalled but may still be in homes. See recall for more information.

What You Should Do:

- Advertisement -
  • Do not use any recalled products. If you have any of these recalled products in your home, throw them out or return them to the store.
  • Wash items and surfaces that may have touched the recalled products using hot soapy water or a dishwasher.
  • Call your healthcare provider if you have any severe Salmonella symptoms.

About Salmonella: 

  • Most people infected with Salmonella develop diarrhea, fever, and stomach cramps 6 hours to 6 days after being exposed to the bacteria.
  • The illness usually lasts 4 to 7 days, and most people recover without treatment.
  • In some people, the illness may be so severe that the patient is hospitalized.
  • Children younger than 5, adults 65 and older, and people with weakened immune systems are more likely to have severe illness.

If you have questions about cases in a particular state, please call that state’s health department.

Information source: CDC

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Approves First Factor Xla Inhibitor to Help Prevent Stroke in Certain Adults at High Risk 

The U.S. Food and Drug Administration today approved Sunharbo (asundexian) 50 mg tablets, the first factor XIa (FXIa) inhibitor for use in combination with antiplatelet therapy to reduce the risk of stroke in adults following a recent mild-to-moderate non-cardioembolic ischemic stroke (a stroke caused by a clot that did not originate in the heart) or a high-risk transient ischemic attack (TIA), often called a “mini-stroke.” 

Practical Health Tips to Navigate Cold and Flu Season Safely

With cold and flu season in full swing, experts say there are some simple steps you can take to protect yourself and those around you.

DHR Health Expands Ophthalmology Services with Addition of Dr. Rachel Gelman

 Continuing its mission to provide exceptional medical care to patients across the Rio Grande Valley, DHR Health is pleased to welcome ophthalmologist Dr. Rachel Gelman to its team of healthcare providers.

STHS McAllen Welcomes Aspiring Youth for an Interactive Look Inside Healthcare

As the demand for healthcare professionals continues to grow, introducing young students to the wide range of opportunities available in the medical field is more important than ever. From nurses and physicians to emergency responders, pharmacists and other essential healthcare workers, each plays a critical role in caring for patients and keeping communities healthy.
- Advertisement -